Barbara Cipriani

Barbara Cipriani

Company: Pathios Therapeutics

Job title: Vice President, Biology


Validation of GPR65 as a Novel Immuno-oncology Target using Advanced In Vitro & In Vivo Models 4:30 pm

Identification of GPR65 as a novel immuno-oncology target as well as potent GPR65 inhibitors Provide additional validation using primary tumorhistocultures and genetically engineered mice Advancing biomarker development to accelerate clinical developmentRead more

day: Day One PM

TRACK A: Target ID & Validation
10:35 am

Read more

day: Day One Track A AM

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.